(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
The Tourette Syndrome and Tic Disorder Clinic at Cincinnati Children's is home to specialists with a variety of backgrounds and areas of focus. As a team, this diversity makes us better prepared to care for your child's unique needs.
Donald L. Gilbert, MD, MS Director, Movement Disorder Clinic and Tourette's Syndrome Clinic 513-636-4222 email@example.com
Director, Movement Disorder Clinic and Tourette's Syndrome Clinic
Professor, UC Department of Pediatrics
Movement disorders; Tourette's syndrome; Sydenham's chorea; kernicterus; dystonia; ataxia; clinical research; transcranial magnetic stimulation
Donald Gilbert, MD, earned his Bachelor of Arts at Princeton University, where he majored in philosophy. He subsequently earned his MD at the University of Michigan and spent a year at the National Institutes of Health as a Howard Hughes Medical Institute Research Scholar. Dr. Gilbert did his pediatrics and neurology training at John Hopkins in Baltimore and is board certified in neurology with special competence in child neurology. Dr. Gilbert has an MS in clinical research design and statistical analysis from the University of Michigan.
At Cincinnati Children's, Dr. Gilbert directs the Movement Disorders and Tourette's Syndrome Clinics, which specialize in evaluation and pharmacologic treatment of tics, chorea, tremor, dystonia, stereotypies, ataxia, and other movement disorders. Dr. Gilbert directs or participates in a number of single and multi-center studies into causes and treatments of Tourette's syndrome. Dr. Gilbert directs the Transcranial Magnetic Stimulation Laboratory at Cincinnati Children's.
BA: Princeton University, Princeton, NJ, 1987.
MD: University of Michigan School of Medicine, Ann Arbor, MI, 1993.
MS: University of Michigan, Ann Arbor, MI, 2003.
Pediatrics, Child Neurology Residency: Johns Hopkins School of Medicine, Baltimore, MD, 1998.
Certification: Board Certified in Neurology with Special Competence in Child Neurology, 2010; Board eligible in Pediatrics.
Appointment: Professor of Pediatric Neurology.
Hong YH, Wu SW, Pedapati EV, Horn PS, Huddleston DA, Laue CS, Gilbert DL. Safety and Tolerability of Theta Burst Stimulation versus Single and Paired Pulse Transcranial Magnetic Stimulation: A Comparative Study of 164 Pediatric Subjects. Frontiers in Neuroscience. 2015. doi: 10.3389/fnhum.2015.00029
Dietrich A, Fernandez TV, King RA, State MW, Tischfield JA, Hoekstra PJ, Heiman GA, and the TIC Genetics Collaborative Group. The Tourette International Collaborative Genetics (TIC Genetics) study, finding the genes causing Tourette Syndrome: objectives and methods. Eur Child Adolesc Psychiatry, 2014. DOI 10.1007/s00787-014-0543-x
Gilbert DL, Budman CL, Singer HS, Kurlan R, Chipkin RE. A D1 Receptor Antagonist, Ecopipam, for treatment of tics in Tourette Syndrome. Clinical Neuropharmacology, 2014. 37:26-30.
Chen TH, Wu SW, Dixon S, Shahana N, Huddleston DA, Sarvis AR, Sallee FR, Gilbert DL. Motor Cortex Physiology and Stop Signal Reaction Times as Predictors and Correlates of Atomoxetine Responses in Children with ADHD. Journal of Child Neurology, 2014. 29:1672-9. DOI: 10.1177/0883073813513333.
Wu SW, Maloney T, Gilbert DL, Dixon SG, Horn PS, Huddleston DA, Eaton K, Vannest J. Functional MRI-navigated Repetitive Transcranial Magnetic Stimulation of Supplementary Motor Area in Chronic Tic Disorders. Brain Stimulation. 2014. 7: 212-218.
Gilbert DL, Patterson MC, Pugh JA, Ridel KR, Reynolds TQ, Valencia I. Views of Recently First-Certified US Child Neurologists on Their Residency Training. Journal of Child Neurology, 2013. 28 (3): 332-339. doi 10.1177/0883073812473644.
Wu SW, Shahana N, Huddleston DA, Gilbert DL. Effects of 30 Hz Theta Burst Transcranial Magnetic Stimulation on the primary motor cortex. Journal of Neuroscience Methods, 2012; 208: 161-164.
Wu SW, Gilbert DL, Shahan N, Huddleston DA, Mostofsky SH. Transcranial Magnetic Stimulation Measures in Attention Deficit/Hyperactivity Disorder. Pediatric Neurology, 2012; 47: 177-185. Doi: 10.1016/j.pediatricneurol.2012.06.0003.
Wu SW, Shahana N, Huddleston DA, Lewis AN, Gilbert DL. Safety and Tolerability of Theta Burst Stimulation in Children. Developmental Medicine and Child Neurology. 2012, 54 (7): 636-639. Doi: 10.111/j.1469-8749.2012.04300.x.
Edden RAE, Crocetti D, Zhu H, Gilbert DL, Mostofsky SH. Reduced GABA concentration in Attention Deficit/Hyperactivity Disorder. Archives of General Psychiatry. 2012; 69: 750-753. PMID: 22752239.
Steve W. Wu, MD Director, Dsytonia and Movement Disorder Clinic 513-636-4222 firstname.lastname@example.org
Director, Dsytonia and Movement Disorder Clinic
Assistant Professor, UC Department of Pediatrics
Pediatric neurology with specialty in pediatric movement disorder; botulinum toxin (Botox) injection for dystonia, spasticity, tics; deep brain stimulation (DBS)
Dr. Steve Wu is a pediatric neurologist with interests in children with movement disorders. Drs. Wu, Gilbert (Neurology) and Vadivelu (Neurosurgery) also work together in the Dystonia/Deep Brain Stimulation Clinic to care for children/adolescents with dystonia and complex movement disorders.
Dr. Wu’s research interest focuses on movement disorders and neuroplasticity of the brain. Dr. Wu collaborates with Dr. Donald Gilbert in the Transcranial Magnetic Stimulation Lab at Cincinnati Children’s Hospital Medical Center.
BA: University of California, Berkeley, CA, 1997.
MD: Vanderbilt University, Nashville, TN, 2003.
Residency: Pediatrics and Pediatric Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2003-2008.
Fellowship: Pediatric Movement Disorders, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2008-2009.
Wu SW, Gilbert DL. Measuring neuroplasticity in children using brain stimulation (Commentary). Dev Med Child Neurol. 2015.
Hong YH, Wu SW, Pedapati EV, Horn PS, Huddleston DA, Laue CS, Gilbert DL. Safety and Tolerability of Theta Burst Stimulation versus Single and Paired Pulse Transcranial Magnetic Stimulation: A Comparative Study of 165 Pediatric Subjects. Front Hum Neurosci. 2015.
Burrow TA, Sun Y, Prada CE, Bailey L, Zhang W, Brewer A, Wu SW, Setchell K, Witte D, Cohen MB, Grabowski GA. CNS, Lung, and Lymph Node involvement in Gaucher disease type 3 after 11 years therapy: Clinical, Histopathologic, and Biochemical Findings. Mol Genet Metab. 2014.
Chen TH, Wu SW, Dixon S, Shahana N, Huddleston DA, Sarvis AR, Sallee FR, Gilbert DL. Reduced short interval cortical inhibition correlates with atomoxetine response in children with attention-deficit hyperactivity disorder (ADHD). J Child Neurol. 2014;29:1672-9.
Wu SW, Maloney T, Gilbert DL, Dixon SG, Horn PS, Huddleston DA, Eaton K, Vannest J. Functional MRI-navigated Repetitive Transcranial Magnetic Stimulation over Supplementary Motor Area in Chronic Tic Disorders. Brain Stimulation. 2014;7(2):212–218.
Hedera P, Xiao J, Puschmann A, Momčilović D, Wu SW, LeDoux MS. Novel PRRT2 mutation in an African-American family with paroxysmal kinesigenic dyskinesia. BMC Neurology. 2012;12:93.
Klotz J, Johnson M, Wu SW, Isaacs KM, Gilbert DL. Relationship between Reaction Time Variability and Motor Skill Development in ADHD. Child Neuropsychology. 2012;18:576-585.
Wu SW, Gilbert DL, Shahana N, Huddleston DA, Mostofsky SH. Transcranial Magnetic Stimulation Measures in Attention-Deficit/Hyperactivity Disorder. Pediatric Neurology. 2012;47:177-185.
Wu SW, Shahana N, Huddleston DA, Gilbert DL. Effects of 30 Hz Theta Burst Transcranial Magnetic Stimulation on the Primary Motor Cortex. Journal of Neuroscience Methods. 2012;208:161-164.
Wu SW, Shahana N, Huddleston DA, Lewis AN, Gilbert DL. Safety and Tolerability of Theta-Burst Transcranial Magnetic Stimulation in Children. Developmental Medicine and Child Neurology. 2012;54:636-639.
Tara D. Lipps, MSN, APRN, CNP Nurse Practitioner, Division of Neurology 513-636-4222 email@example.com
Nurse Practitioner, Division of Neurology
Nurse Practitioner, Movement Disorders and Tourette Syndrome Clinic
Movement disorders and Tourette's syndrome; general neurology; headaches; epilepsy
Tara Lipps has worked at Cincinnati Children's Hospital Medical Center in the Division of Neurology for 13 years in the Movement Disorders and Tourette Syndrome Clinic in various roles. She worked as a clinical and research nurse for three years initially, and she has worked as a nurse practitioner and researcher for the past 10 years. She provides clinical care for a large population of patients in the clinic and has additional training and experience in comprehensive behavioral therapy for tics (CBIT).
In addition, she works as a nurse practitioner in general neurology clinics and manages the care of patients with a variety of complex neurological conditions.
MSN, CFNP: Northern Kentucky University, Highland Heights, KY.
RN, BSN: Northern Kentucky University, Highland Heights, KY.
Certification: CFNP (Certified Family Nurse Practitioner), AANP (American Academy of Nurse Practitioners), 2004.
Ridel, Keith R, Lipps, Tara D, Gilbert, Donald L. The Prevalence of Neuropsychiatric Disorders in Sydenham's Chorea. Pediatric Neurology. 2009.
Gilbert DL, Zhang J, Lipps TD, Natarajan N, Brandyberry J, Wang Z, Sallee FR, Wassermann EM. Atomoxetine Treatment of ADHD in Tourette Syndrome: Reduction in Motor Cortex Inhibition Correlates with Clinical Improvement. Clinical Neurophysiology. 2007; 118:1835-1841.
Gilbert DL, Wang Z, Sallee FR, Ridel KR, Merhar S, Zhang J, Lipps TD, White C, Badreldin N, Wassermann EM. Dopamine transporter genotype influences the physiological response to medication in ADHD. Brain. 2006; 129:2038-2046.
Gilbert DL, Ridel KR, Sallee FR, Zhang J, Lipps T, Wassermann E. Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology. 2006;31:442-449.
Gilbert DL, Lipps TD. Tourette Syndrome. Current Treatment Options in Neurology. 2005;7:211-219.
Gilbert DL, Sallee FR, Zhang J, Lipps T, Wassermann EM. TMS-evoked cortical inhibition, a consistent marker of ADHD scores in Tourette Syndrome. Biological Psychiatry. 2005.
Gilbert DL, Bansal AS, Sethuraman G, Huff T, Zhang J, Sallee FR, Wassermann EM. Association of Cortical Disinhibition with tic, ADHD, and OCD Severity in Tourette Syndrome. Movement Disorders. 2004;19:416-425.
Gilbert DL, Garvey M, Bansal AS, Huff T, Zhang J, Wassermann EM. Should Transcranial Magnetic Research in Children be Considered Minimal Risk? Clinical Neurophysiology. 2004; 18: 1730-1739.
Elana Harris, MD, PhD 513-636-2100 firstname.lastname@example.org
UC Department of Psychiatry and Behavioral Neuroscience
Conditions: anxiety disorders; obsessive compulsive disorder; Tourette syndrome; trichotillomania
Treatment modalities: habit reversal therapy; pharmacotherapy
MD: State University of New York, Downstate Medical Center.
PhD: Neural and Behavioral Science; State University of New York, Downstate Medical Center.
Internship: Pediatrics, Winthrop University Hospital, Mineola, NY.
Residency: Psychiatry, Johns Hopkins Hospital, Baltimore, MD.
Fellowship: Child and Adolescent Psychiatry, Johns Hopkins Hospital, Baltimore, MD.
Korostenskaja M, Wilson A, Rose D, Brunner P, Schalk G, Leach J, Mangano F, Fujiwara H, Rozhkov L, Harris E, Chen PC, Seo JH, Lee KH. Real-time functional mapping (RTFM) with ECoG in pediatric epilepsy surgery: comparison with fMRI and ESM findings. EEG and Clinical Neuroscience. 2013.
Korostenskaja M, Harris E, Giovanetti C, Horn P, Wang Y, Rose D, Fujiwara H, Xiang J. Magnetoencephalography reveals altered auditory information processing in youth with obsessive compulsive disorder. Psychiat Res: Neuroim. 2013;212:132-140.
Wu SW, Harris E, Gilbert DL. Tic suppression: the medical model. J. Child Adolesc. Psychopharmacol. 2010;20(4):263-76.
Harris E, Wu S. Children with tic disorders: How to match treatment with symptoms. Current Psychiatry. 2010;9(3):29-36.
Harris E, Eng HY, Kowatch R, Delgado SV, Saldaña SN. Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder. J. Child Adolesc. Psychopharmacol. 2010;20(4):347-33.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2016 Cincinnati Children's Hospital Medical Center